Increased vascular calcification in patients receiving warfarin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 1, 2016, Pages 237-242

  Tantisattamo, Ekamol ^a   Han, Kum Hyun ^a,b   Charles O'Neill, W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inje University College of Medicine   (South Korea)

Author keywords

Anticoagulation; matrix proteins; vascular calcification

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BREAST ARTERIAL CALCIFICATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HUMAN; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RISK FACTOR; SCREENING TEST; TREATMENT DURATION; VERY ELDERLY; BREAST DISEASES; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; DRUG ADMINISTRATION; GEORGIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RADIOGRAPHY; STATISTICAL MODEL; TIME; VASCULAR CALCIFICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BREAST DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GEORGIA; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; TIME FACTORS; VASCULAR CALCIFICATION; WARFARIN;

EID: 84920189309     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304392     Document Type: Article

References (27)

1. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS. Long-term prognosis associated with coronary calcifcation: observations from a registry of 25, 253 patients. J Am Coll Cardiol. 2007;49:1860-1870.
2. Kemmeren JM, van Noord PAH, Beijerinck D, Fracheboud J, Banga JD, van der Graaf Y. Arterial calcifcation found on breast cancer screening mammograms and cardiovascular mortality in women. The DOM project. Am J Epidemiol. 1998;147 333-341.
3. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcifcation. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:978-983.
4. Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H, Qin X. Tibial artery calcifcation as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51: 1967-1974.
5. Allison MA, Hiatt WR, Hirsch AT, Coll JR, Criqui MH. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol. 2008;51:1292-1298.
6. Cecelja M, Chowienczyk P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis. 2012;1:.
7. Lau WL, Ix JH. Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcifcation: a pattern of vascular injury associated with aberrant mineral metabolism. Semin Nephrol. 2013;33:93-105.
8. Lomashvili KA, Wang X, Wallin R, O'Neill WC. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcif-cation. J Biol Chem. 2011;286:28715-28722.
9. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcifcation of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
10. Meier M, Weng LP, Alexandrakis E, Rüschoff J, Goeckenjan G. Tracheobronchial stenosis in Keutel syndrome. Eur Respir J. 2001;17:566-569.
11. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21:142-144.
12. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcifcation of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 1998;18:1400-1407.
13. Weijs B, Blaauw Y, Rennenberg RJ, Schurgers LJ, Timmermans CC, Pison L, Nieuwlaat R, Hofstra L, Kroon AA, Wildberger J, Crijns HJ. Patients using vitamin K antagonists show increased levels of coronary calcifca-tion: an observational study in low-risk atrial fbrillation patients. Eur Heart J. 2011;32:2555-2562.
14. Villines TC, O'Malley PG, Feuerstein IM, Thomas S, Taylor AJ. Does prolonged warfarin exposure potentiate coronary calcifcation in humans? Results of the warfarin and coronary calcifcation study. Calcif Tissue Int. 2009;85:494-500.
15. Koos R, Mahnken AH, Mühlenbruch G, Brandenburg V, Pfueger B, Wildberger JE, Kühl H P. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol. 2005;96:747-749.
16. Rennenberg RJ, van Varik BJ, Schurgers LJ, Hamulyak K, Ten Cate H, Leiner T, Vermeer C, de Leeuw PW, Kroon AA. Chronic coumarin treatment is associated with increased extracoronary arterial calcifcation in humans. Blood. 2010;115:5121-5123.
17. Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y; Japanese Calciphylaxis Study Group. A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant. 2012;27:1580-1584.
18. Nielsen BB, Holm NV. Calcifcation in breast arteries. The frequency and severity of arterial calcifcation in female breast tissue without malignant changes. Acta Pathol Microbiol Immunol Scand A. 1985;93:13-16.
19. O'Neill WC, Adams AL. Breast arterial calcifcation in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdiffer-entiation. Kidney Int. 2014;85:668-676.
20. Duhn V, D'Orsi ET, Johnson S, D'Orsi CJ, Adams AL, O'Neill WC. Breast arterial calcifcation: a marker of medial vascular calcifcation in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:377-382.
21. Hassan NA, D'Orsi ET, D'Orsi CJ, O'Neill WC. The risk for medial arterial calcifcation in CKD. Clin J Am Soc Nephrol. 2012;7:275-279.
22. Koos R, Krueger T, Westenfeld R, Kühl HP, Brandenburg V, Mahnken AH, Stanzel S, Vermeer C, Cranenburg EC, Floege J, Kelm M, Schurgers LJ. Relation of circulating matrix gla-protein and anticoagulation status in patients with aortic valve calcifcation. Thromb Haemost. 2009;101:706-713.
23. Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB. Breast vascular calcifcation and risk of coronary heart disease, stroke, and heart failure. J Womens Health. 2004;13 381-389.
24. Abou-Hassan N, Tantisattamo, E, D'Orsi, ET, O'Neill WC. The clinical sig-nifcance of medial arterial calcifcation in end-stage renal disease [published online ahead of print May 28, 2014]. Kidney Int. doi:10.1038/ki.2014.187. http://www.nature.com/ki/journal/vaop/ncurrent/full/ki2014187a.html.
25. Investigators WAVET. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357:217-227.
26. Romberg RW, Werness PG, Riggs BL, Mann KG. Inhibition of hydroxy-apatite crystal growth by bone-specifc and other calcium-binding proteins. Biochemistry. 1986;25:1176-1180.
27. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D. Post-translational modifcations regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcifcation. J Thromb Haemost. 2007;5:2503-2511.